Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF

Healthcare Biotechnology


GREY:IPHAF - Post by User

Isotechnika Pharma Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by go4futureon May 08, 2009 8:10am
356 Views
Post# 15977296

RE: Paladin Labs

RE: Paladin LabsPaladin Labs (C$16.00, C$1.02, 6.8%) said its first-quarter earnings doubled to C$3.1 million or 20 Canadian cents a share and revenue jumped 53% to C$25.8 million.

Paladin Labs released there Q1 2009 earnings yesterday in a separate announcement which did not mention Isotechnika colaboration (which was released as a separate news announcement). I think the Q1 earnings was the primary driver in the stock price yesterday. They also only have 14.9M shares outstanding.

https://cnrp.marketwire.com/client/paladin_labs/releaseen.jsp?year=2009&actionFor=985886&releaseSeq=1
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities